خدمة انسانية
- بادئ الموضوع الفرازي
- تاريخ البدء
اسلامي
New Member
أخي قد تفيدك هذه الصفحة
Rich (BB code):
أخى الفاضل يفضل وضع طلبك فى قسم طلب الأبحاث بكلية العلوم فهو مخصص لمثل تلك الطلبات
وإن شاء الله ستجد الكثير الكثير من محبى المساعدة سيحاولون جاهدين تلبية طلباتك ابتغاء وجه الله
تقبل تحياتى
وإن شاء الله ستجد الكثير الكثير من محبى المساعدة سيحاولون جاهدين تلبية طلباتك ابتغاء وجه الله
تقبل تحياتى
http://university.arabsbook.com/forum52/thread52347.html
by Lau, Tin-Kit, M.Sc., University of Alberta (Canada), 1990
Pharmacogenetics of Breast Cancer
http://university.arabsbook.com/forum99/thread48420-54.html
1.Targeting bacteriolytic therapy of solid tumors with attenuated Salmonella typhimurium
by Ganai, Sabha, Ph.D., University of Massachusetts Amherst, 2007
2. ERBB family in breast cancer: Detection methods, clinical and prognostic significance, under-recognized mechanisms in their function
by Onody, Peter, Ph.D., Semmelweis Egyetem (Hungary), 2006
3. Predictors of axillary node dissection in ductal carcinoma in situ
by Rakovitch, Eileen, M.Sc., University of Toronto (Canada), 2005
4.Radioisotope-guided surgical techniques for the treatment of early breast cancer
by Peley, Gabor, Ph.D., Semmelweis Egyetem (Hungary), 2005
5. Do variations in treatment of ductal carcinoma in situ affect outcomes?
by Gold, Heather Taffet, Ph.D., The University of Rochester, 2002
6.Evaluating the prognostic value of 8p allelic status in early stage breast cancer patients
by Williams, Tanisha Yarweh, M.S., Georgia State University - College of Arts and Sciences, 2002
7. Justifying the refusal of breast cancer therapy
by Keenan, Louanne Patricia, Ph.D., University of Alberta (Canada), 2002,
8. Estradiol and insulin cross-talk in breast cancer
by Hutchins, Ginny Graham, Ph.D., The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, 2001,
9. p53 and HER2/neu: Breast tumor markers and targets for cancer therapy by Do, Tamara Ngoc, Ph.D., Columbia University, 2001
10.Applications of liposome technology in modulating P-glycoprotein-mediated multidrug resistance by Krishna, Rajesh, Ph.D., The University of British Columbia (Canada), 1999
11 Emotional, physical, and sexual responses in women who experience prophylactic mastectomy and breast reconstruction for the prevention of breast cancer
by Shea Welch, Kelly Jean, Ph.D., Kansas State University, 1999
12 Tomographic patient registration and conformal avoidance tomotherapy
by Aldridge, Jennifer Stacy, Ph.D., The University of Wisconsin - Madison, 1999,
13 Image analysis and mathematical methods for diagnosis in pathology: Applications to neoplastic diseases of the breast, ovary, and parathyroid by Einstein, Andrew Jeffrey, Ph.D., City University of New York, 1998
14. Magnetic resonance imaging developments for the study of breast tumour microvasculature by Maier, Cynthia F., Ph.D., The University of Western Ontario (Canada), 1998,
15. Factors associated with the practice patterns of Florida general surgeons for stage I and stage II breast cancer by Luther, Stephen L., Ph.D., University of South Florida, 1997
16. The glucose-regulated proteins: Altered expression in human breast cancer cell lines and applications in cancer gene therapy in an in vivo mouse model system
by Gazit, Gadi, Ph.D., University of Southern California, 1997
17. Genesis and stabilization of normal breast epithelial cytoarchitecture, and its derangement in breast carcinoma by Bergstraesser, Lynn Marie, Ph.D., Northwestern University, 1996
18. Mechanisms of interferon-tamoxifen interaction
by Lindner, Daniel John, Ph.D., The Medical College of Wisconsin, 1996,
19. Risk of recurrence following ductal carcinoma in situ of the breast
by Habel, Laurel Anne, Ph.D., University of Washington, 1996
20. In search of breast carcinoma: A mammographic asymmetry approachby Ganai, Sabha, Ph.D., University of Massachusetts Amherst, 2007
2. ERBB family in breast cancer: Detection methods, clinical and prognostic significance, under-recognized mechanisms in their function
by Onody, Peter, Ph.D., Semmelweis Egyetem (Hungary), 2006
3. Predictors of axillary node dissection in ductal carcinoma in situ
by Rakovitch, Eileen, M.Sc., University of Toronto (Canada), 2005
4.Radioisotope-guided surgical techniques for the treatment of early breast cancer
by Peley, Gabor, Ph.D., Semmelweis Egyetem (Hungary), 2005
5. Do variations in treatment of ductal carcinoma in situ affect outcomes?
by Gold, Heather Taffet, Ph.D., The University of Rochester, 2002
6.Evaluating the prognostic value of 8p allelic status in early stage breast cancer patients
by Williams, Tanisha Yarweh, M.S., Georgia State University - College of Arts and Sciences, 2002
7. Justifying the refusal of breast cancer therapy
by Keenan, Louanne Patricia, Ph.D., University of Alberta (Canada), 2002,
8. Estradiol and insulin cross-talk in breast cancer
by Hutchins, Ginny Graham, Ph.D., The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, 2001,
9. p53 and HER2/neu: Breast tumor markers and targets for cancer therapy by Do, Tamara Ngoc, Ph.D., Columbia University, 2001
10.Applications of liposome technology in modulating P-glycoprotein-mediated multidrug resistance by Krishna, Rajesh, Ph.D., The University of British Columbia (Canada), 1999
11 Emotional, physical, and sexual responses in women who experience prophylactic mastectomy and breast reconstruction for the prevention of breast cancer
by Shea Welch, Kelly Jean, Ph.D., Kansas State University, 1999
12 Tomographic patient registration and conformal avoidance tomotherapy
by Aldridge, Jennifer Stacy, Ph.D., The University of Wisconsin - Madison, 1999,
13 Image analysis and mathematical methods for diagnosis in pathology: Applications to neoplastic diseases of the breast, ovary, and parathyroid by Einstein, Andrew Jeffrey, Ph.D., City University of New York, 1998
14. Magnetic resonance imaging developments for the study of breast tumour microvasculature by Maier, Cynthia F., Ph.D., The University of Western Ontario (Canada), 1998,
15. Factors associated with the practice patterns of Florida general surgeons for stage I and stage II breast cancer by Luther, Stephen L., Ph.D., University of South Florida, 1997
16. The glucose-regulated proteins: Altered expression in human breast cancer cell lines and applications in cancer gene therapy in an in vivo mouse model system
by Gazit, Gadi, Ph.D., University of Southern California, 1997
17. Genesis and stabilization of normal breast epithelial cytoarchitecture, and its derangement in breast carcinoma by Bergstraesser, Lynn Marie, Ph.D., Northwestern University, 1996
18. Mechanisms of interferon-tamoxifen interaction
by Lindner, Daniel John, Ph.D., The Medical College of Wisconsin, 1996,
19. Risk of recurrence following ductal carcinoma in situ of the breast
by Habel, Laurel Anne, Ph.D., University of Washington, 1996
by Lau, Tin-Kit, M.Sc., University of Alberta (Canada), 1990
Pharmacogenetics of Breast Cancer
http://university.arabsbook.com/forum99/thread48420-54.html